Research & Development Manager | Dr. Annamarija Raic
[vc_row][vc_column][vc_column_text] Research manager Dr. Annamarija Raic joined faCelliate in October 2020 and contributes her years of experience in the field of synthetic biomaterials and stem cell biology to the innovation of new products. During her time as PhD student and Post
COO & Co-founder | Dr. Simon Widmaier
[vc_row][vc_column][vc_column_text] Dr. Simon Widmaier has a biophysics background and a PhD in molecular simulation from the Karlsruhe Institute of Technology. In addition, he has founded four successful start-ups within the last 10 years, the latest with focus on a miniatured screening
CEO & Co-founder | Dr. Véronique Schwartz
[vc_row][vc_column][vc_column_text] Dr. Véronique Schwartz holds a PhD in polymer science and has initiated and conducted a multitude of interdisciplinary projects at the interface between biology and chemistry during her PhD at the Max Planck Institute of Polymer Research as well as
faCellitate’s BIOFLOAT™ product line for Drug Discovery World – Summer 2020 issue
faCellitate joined other cell culture technology leaders in the discussion on how innovations in physiologically relevant cell culture models may help increasing the chances of success in drug discovery. Read the article in the Summer 2020 issue of Drug Discovery